Turtle Creek Wealth Advisors »

Acelrx Pharmaceuticals shares owned by Turtle Creek Wealth Advisors

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Turtle Creek Wealth Advisors from 13F filings

Historical chart of Turtle Creek Wealth Advisors investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Turtle Creek Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Turtle Creek Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $74k 72k 1.03
2023-12-31 $17k 24k 0.74

More positions owned by Turtle Creek Wealth Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Msci Eafe (IEFA)
Select Sector Spdr Tr Technology (XLK)
Blue Owl Capital Com Cl A (OWL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Apple (AAPL)
Ishares Core Msci Emkt (IEMG)
Ishares Tr Core S&p Ttl Stk (ITOT)
JPMorgan Chase & Co. (JPM)
Lam Research Corporation (LRCX)
Ishares Tr Rus 1000 Etf (IWB)
Caterpillar (CAT)
Kla Corp Com New (KLAC)
NVIDIA Corporation (NVDA)

View all positions for Turtle Creek Wealth Advisors

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Cantor Fitzgerald, L. P.
Tang Capital Management
Vanguard Group
Values First Advisors
Turtle Creek Wealth Advisors
Virtu Financial
Citadel Advisors
Millennium Management
Jane Street
UBS Group
Advisor Group Holdings
Wells Fargo & Company
Advisory Services Network

View all funds holding Acelrx Pharmaceuticals